SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...

Biotech stocks remain a hot sector for retail traders on Stocktwits, which collectively boast over 3.45 million followers. In ...

After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

The China-based drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is ...

Research photo from the National Cancer Institute, shared via Unsplash. (NCI Photo) When Luca Foschini, head of Seattle's ...

A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

A Bay Area biotech is suing its insurance company to cover costs associated with patients allegedly injured during clinical ...